Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Aflac Inc. (AFL) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Insurance - Life
$108.71
-0.92 (-0.84%)Did AFL Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Aflac is one of their latest high-conviction picks.
Based on our analysis of 24 Wall Street analysts, AFL has a neutral consensus with a median price target of $116.00 (ranging from $100.00 to $130.00). The overall analyst rating is Hold (5.8/10). Currently trading at $108.71, the median forecast implies a 6.7% upside. This outlook is supported by 3 Buy, 7 Hold, and 3 Sell ratings.
Conversely, the most conservative target is provided by Jimmy Bhullar at JP Morgan, suggesting a 8.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for AFL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 25, 2026 | Wells Fargo | Wesley Carmichael | Equal-Weight | Maintains | $118.00 |
| Jan 8, 2026 | Barclays | Alex Scott | Underweight | Maintains | $101.00 |
| Jan 5, 2026 | JP Morgan | Jimmy Bhullar | Neutral | Maintains | $105.00 |
| Dec 30, 2025 | Raymond James | Wilma Burdis | Outperform | Maintains | $119.00 |
| Dec 22, 2025 | TD Cowen | Daniel Bergman | Hold | Maintains | $102.00 |
| Dec 16, 2025 | Mizuho | Yaron Kinar | Underperform | Initiates | $104.00 |
| Nov 17, 2025 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $118.00 |
| Nov 7, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $109.00 |
| Nov 7, 2025 | Evercore ISI Group | Thomas Gallagher | Underperform | Maintains | $111.00 |
| Nov 5, 2025 | JP Morgan | Jimmy Bhullar | Neutral | Maintains | $101.00 |
| Nov 5, 2025 | Barclays | Alex Scott | Underweight | Maintains | $104.00 |
| Oct 9, 2025 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $110.00 |
| Oct 9, 2025 | Evercore ISI Group | Thomas Gallagher | Underperform | Maintains | $110.00 |
| Oct 8, 2025 | Barclays | Alex Scott | Underweight | Maintains | $102.00 |
| Aug 18, 2025 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $113.00 |
| Aug 15, 2025 | Evercore ISI Group | Thomas Gallagher | Underperform | Maintains | $106.00 |
| Aug 11, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $107.00 |
| Aug 11, 2025 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $108.00 |
| Aug 6, 2025 | UBS | Brian Meredith | Neutral | Maintains | $111.00 |
| Jul 14, 2025 | Morgan Stanley | Equal-Weight | Maintains | $N/A |
The following stocks are similar to Aflac based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Aflac Inc. has a market capitalization of $56.61B with a P/E ratio of 16.1x. The company generates $17.16B in trailing twelve-month revenue with a 21.2% profit margin.
Revenue growth is -9.9% quarter-over-quarter, while maintaining an operating margin of +33.6% and return on equity of +13.1%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides supplemental health and life insurance.
The company operates through two main segments: Aflac Japan, which primarily sells individual medical and cancer policies through various distribution channels, and Aflac U.S., which focuses on individual and employer-sponsored group policies. Revenue is generated from premiums paid by policyholders for a variety of supplemental insurance products that cover out-of-pocket expenses not typically covered by primary health insurance.
Founded in 1955 and headquartered in Columbus, Georgia, Aflac Inc. has established a significant presence in both the U.S. and Japan, reinforcing its role in the global insurance market by offering tailored supplemental protection to meet diverse consumer needs.
Financial Services
Insurance - Life
12,716
Mr. Daniel Paul Amos
United States
1984
Aflac (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aflac (AFL) recently reported earnings. Investors should monitor upcoming developments and stock performance following the earnings report.
Aflac's recent earnings report may influence stock performance, impacting investor sentiment and expectations for future growth and profitability.
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, outperforming SPY's 1.08%. However, dividend growth is slowing, averaging 3.22% this year.
NOBL's strong YTD performance highlights a shift towards dividend-paying stocks, while lagging dividend growth may indicate future challenges for income-focused investments.
Many stocks are perceived to yield only 2% or less, indicating potential investor sentiment about the returns of these investments.
The mention of stocks yielding 2% or less indicates potential undervaluation or hidden opportunities, prompting investors to reassess dividend strategies and explore higher-yield options.
In December, dividend income totaled $8,010.54, with $4.44 from increases. The accounts include HSA investments, ROTH and traditional IRAs, and 401(k) accounts.
Dividend income reflects financial health and investment returns, signaling potential growth in portfolios. Increased passive income indicates solid performance and can attract more investors.
Aflac Incorporated (AFL) presented at the UBS Financial Services Conference 2026, highlighting key information relevant for investors.
Aflac's presentation at the UBS Conference signals potential insights into its financial health and strategy, impacting investor sentiment and stock valuation.
In 2026, trade rotation dominates the stock market narrative, with AI hyperscalers investing heavily, but their efforts are not yielding the same rewards as in prior years.
The shift in trade rotation signals changing investor sentiment, impacting AI hyperscalers' stock performance and highlighting a potential reevaluation of growth expectations in the sector.
Based on our analysis of 24 Wall Street analysts, Aflac Inc. (AFL) has a median price target of $116.00. The highest price target is $130.00 and the lowest is $100.00.
According to current analyst ratings, AFL has 3 Buy ratings, 7 Hold ratings, and 3 Sell ratings. The stock is currently trading at $108.71. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict AFL stock could reach $116.00 in the next 12 months. This represents a 6.7% increase from the current price of $108.71. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates through two main segments: Aflac Japan, which primarily sells individual medical and cancer policies through various distribution channels, and Aflac U.S., which focuses on individual and employer-sponsored group policies. Revenue is generated from premiums paid by policyholders for a variety of supplemental insurance products that cover out-of-pocket expenses not typically covered by primary health insurance.
The highest price target for AFL is $130.00 from at , which represents a 19.6% increase from the current price of $108.71.
The lowest price target for AFL is $100.00 from Jimmy Bhullar at JP Morgan, which represents a -8.0% decrease from the current price of $108.71.
The overall analyst consensus for AFL is neutral. Out of 24 Wall Street analysts, 3 rate it as Buy, 7 as Hold, and 3 as Sell, with a median price target of $116.00.
Stock price projections, including those for Aflac Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.